Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Thermal Ablation in the Management of Colorectal Cancer Patients with Oligometastatic Liver Disease.

Petre EN, Sofocleous C.

Visc Med. 2017 Mar;33(1):62-68. doi: 10.1159/000454697. Epub 2017 Feb 3. Review.

PMID:
28612019
2.

Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data.

Shamimi-Noori S, Gonsalves CF, Shaw CM.

Semin Intervent Radiol. 2017 Jun;34(2):145-166. doi: 10.1055/s-0037-1602712. Epub 2017 Jun 1. Review.

PMID:
28579683
3.

Imaging to optimize liver tumor ablation.

Pua BB, Sofocleous CT.

Imaging Med. 2010 Aug;2(4):433-443.

4.

Comparison of Hepatic Resection and Radiofrequency Ablation for the Treatment of Colorectal Liver Metastasis.

Kim WW, Kim KH, Kim SH, Kim JS, Park SJ, Kim KH, Choi CS, Choi YK.

Indian J Surg. 2015 Dec;77(Suppl 3):1126-30. doi: 10.1007/s12262-015-1211-1. Epub 2015 Mar 24.

5.

Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases.

Sag AA, Selcukbiricik F, Mandel NM.

World J Gastroenterol. 2016 Mar 21;22(11):3127-49. doi: 10.3748/wjg.v22.i11.3127. Review.

6.

Percutaneous ablation of colorectal lung metastases.

Ridge CA, Solomon SB.

J Gastrointest Oncol. 2015 Dec;6(6):685-92. doi: 10.3978/j.issn.2078-6891.2015.095. Review.

7.

Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.

Shady W, Petre EN, Gonen M, Erinjeri JP, Brown KT, Covey AM, Alago W, Durack JC, Maybody M, Brody LA, Siegelbaum RH, D'Angelica MI, Jarnagin WR, Solomon SB, Kemeny NE, Sofocleous CT.

Radiology. 2016 Feb;278(2):601-11. doi: 10.1148/radiol.2015142489. Epub 2015 Aug 12.

8.

Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontières meeting 2013.

Gillams A, Goldberg N, Ahmed M, Bale R, Breen D, Callstrom M, Chen MH, Choi BI, de Baere T, Dupuy D, Gangi A, Gervais D, Helmberger T, Jung EM, Lee F, Lencioni R, Liang P, Livraghi T, Lu D, Meloni F, Pereira P, Piscaglia F, Rhim H, Salem R, Sofocleous C, Solomon SB, Soulen M, Tanaka M, Vogl T, Wood B, Solbiati L.

Eur Radiol. 2015 Dec;25(12):3438-54. doi: 10.1007/s00330-015-3779-z. Epub 2015 May 22.

9.

Non-operative therapies for colorectal liver metastases.

Nosher JL, Ahmed I, Patel AN, Gendel V, Murillo PG, Moss R, Jabbour SK.

J Gastrointest Oncol. 2015 Apr;6(2):224-40. doi: 10.3978/j.issn.2078-6891.2014.065. Review.

10.

Management of oligometastatic rectal cancer: is liver first?

Mitin T, Enestvedt CK, Thomas CR Jr.

J Gastrointest Oncol. 2015 Apr;6(2):201-7. doi: 10.3978/j.issn.2078-6891.2014.086. Review.

11.

Radiofrequency ablation and breast cancer: a review.

Nguyen T, Hattery E, Khatri VP.

Gland Surg. 2014 May;3(2):128-35. doi: 10.3978/j.issn.2227-684X.2014.03.05. Review.

12.

Optimal management of colorectal liver metastases in older patients: a decision analysis.

Yang S, Alibhai SM, Kennedy ED, El-Sedfy A, Dixon M, Coburn N, Kiss A, Law CH.

HPB (Oxford). 2014 Nov;16(11):1031-42. doi: 10.1111/hpb.12292. Epub 2014 Jun 24. Review.

13.

Impact of treatment modality and number of lesions on recurrence and survival outcomes after treatment of colorectal cancer liver metastases.

Saxena A, Chua TC, Chu FC, Ng KM, Herle P, Morris DL.

J Gastrointest Oncol. 2014 Feb;5(1):46-56. doi: 10.3978/j.issn.2078-6891.2013.055.

14.

Evaluation of YO-PRO-1 as an early marker of apoptosis following radiofrequency ablation of colon cancer liver metastases.

Fujisawa S, Romin Y, Barlas A, Petrovic LM, Turkekul M, Fan N, Xu K, Garcia AR, Monette S, Klimstra DS, Erinjeri JP, Solomon SB, Manova-Todorova K, Sofocleous CT.

Cytotechnology. 2014 Mar;66(2):259-73. doi: 10.1007/s10616-013-9565-3. Epub 2013 Sep 25.

15.

Current oncologic applications of radiofrequency ablation therapies.

Shah DR, Green S, Elliot A, McGahan JP, Khatri VP.

World J Gastrointest Oncol. 2013 Apr 15;5(4):71-80. doi: 10.4251/wjgo.v5.i4.71.

16.

Radiofrequency ablation or resection for small colorectal liver metastases - a plea for caution.

Julianov A.

Quant Imaging Med Surg. 2013 Apr;3(2):63-6. doi: 10.3978/j.issn.2223-4292.2013.04.01. No abstract available.

17.

Radiofrequency ablation of metastatic lesions from breast cancer.

Bortolotto C, Macchi S, Veronese L, Dore R, Draghi F, Rossi S.

J Ultrasound. 2012 Sep;15(3):199-205. doi: 10.1016/j.jus.2012.06.007. Epub 2012 Jun 27.

18.

Radiofrequency ablation of liver metastases from colorectal cancer: a literature review.

Minami Y, Kudo M.

Gut Liver. 2013 Jan;7(1):1-6. doi: 10.5009/gnl.2013.7.1.1. Epub 2012 Dec 5.

19.

Role of contrast enhanced ultrasound in radiofrequency ablation of metastatic liver carcinoma.

Wu JY, Chen MH, Yang W, Lin SZ, Wu W, Yin SS, Zhang H, Yan K.

Chin J Cancer Res. 2012 Mar;24(1):44-51. doi: 10.1007/s11670-012-0044-8.

20.

Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.

Abdalla EK, Bauer TW, Chun YS, D'Angelica M, Kooby DA, Jarnagin WR.

HPB (Oxford). 2013 Feb;15(2):119-30. doi: 10.1111/j.1477-2574.2012.00597.x.

Supplemental Content

Support Center